Petrus Trust Company LTA Makes New Investment in Mettler-Toledo International, Inc. $MTD

Key Points

• Petrus Trust Company LTA acquired a new stake in Mettler-Toledo International, purchasing 232 shares valued at approximately $274,000.
• Several large investors, including D. E. Shaw & Co. Inc., significantly increased their holdings in Mettler-Toledo International, with D.E. Shaw boosting its stake by 212%.
• Analysts have mixed ratings for Mettler-Toledo, with five maintaining a Buy rating and five a Hold rating, and a consensus price target of $1,311.11.

Petrus Trust Company LTA bought a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 232 shares of the medical instruments supplier's stock, valued at approximately $274,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. WPG Advisers LLC purchased a new position in Mettler-Toledo International in the first quarter valued at $41,000. Zions Bancorporation National Association UT purchased a new position in Mettler-Toledo International in the first quarter valued at $43,000. Golden State Wealth Management LLC increased its holdings in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after buying an additional 35 shares in the last quarter. Menard Financial Group LLC purchased a new position in Mettler-Toledo International in the fourth quarter valued at $67,000. Finally, Blue Trust Inc. increased its holdings in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after buying an additional 52 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Insider Activity

In other news, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director directly owned 283 shares of the company's stock, valued at approximately $368,154.70. The trade was a 78.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Stock Down 1.9%

NYSE:MTD traded down $24.66 on Friday, hitting $1,258.06. The stock had a trading volume of 109,047 shares, compared to its average volume of 118,112. The stock has a market cap of $25.92 billion, a price-to-earnings ratio of 31.86, a PEG ratio of 3.78 and a beta of 1.37. The company has a fifty day moving average price of $1,258.94 and a two-hundred day moving average price of $1,184.82. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International's revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the business posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Evercore ISI dropped their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research report on Monday, August 4th. Bank of America lifted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Citigroup boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research report on Thursday, August 21st. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price target for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Finally, Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of "Moderate Buy" and a consensus price target of $1,311.11.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.